Venous & microcirculation
One of 5 mechanistic pathways to 🫀 Heart, cholesterol & blood pressure · 10 options
The forgotten half of the circulation. Veins return blood against gravity using valves and vessel-wall tone, and when that fails you get varicosities, heaviness, oedema and haemorrhoids. Different tissue, different mechanism, and genuinely responsive to flavonoids — this is one of the better-evidenced areas in botanical medicine and one of the least discussed.
Venous disease is a different problem from arterial disease and gets far less attention. D-dimer is the screen worth having if swelling is asymmetric or sudden.
D-DimerFibrinogen ActivityComplete Blood Count (CBC) with DifferentialFerritin🩸 Clotting & Advanced Cardiac Risk covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
🧬 Diosmin
A micronised flavonoid with substantial European trial evidence for chronic venous insufficiency and haemorrhoids. Increases venous tone and reduces capillary permeability — prescription-grade in several countries.
🧬 Hesperidin
Diosmin's standard partner; the micronised purified flavonoid fraction is the combination that was actually trialled.
🧬 Citrus Bioflavonoids
The broader complex containing both, plus naringin.
🧬 Horse Chestnut
Escin reduces leg oedema and the symptoms of venous insufficiency in a Cochrane review — comparable to compression stockings in some trials, which is a decent benchmark.
🧬 Butcher's Broom
Ruscogenins increase venous tone via alpha-adrenergic activity on the vessel wall. Trial evidence for chronic venous insufficiency.
🧬 Pycnogenol
Trials cover both venous insufficiency and the microcirculation, including reduced oedema on long flights.
🧬 Bilberry
Anthocyanins strengthen capillary walls and support retinal microcirculation specifically — the RAF-pilot-night-vision story is a myth, the capillary evidence is not.
🧬 Grape Seed Extract
Proanthocyanidins with venous and capillary trial data.
🧬 Nattokinase
Fibrinolytic activity where stasis and clot risk are the concern.
🧬 Vitamin C
Collagen cofactor for the vessel wall itself — scurvy presents as capillary fragility for exactly this reason.
The other 4 routes to heart, cholesterol & blood pressure
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
Want the protocols behind these?
Dosing schedules, stacking, cycle timing and Coach Cam's notes live inside the Academy — plus the full interactive Vault.
Join the Academy — $10/mo →← Open this pathway in the interactive Vault
Frequently asked questions
The forgotten half of the circulation. Veins return blood against gravity using valves and vessel-wall tone, and when that fails you get varicosities, heaviness, oedema and haemorrhoids. Different tissue, different mechanism, and genuinely responsive to flavonoids — this is one of the better-evidenced areas in botanical medicine and one of the least discussed.
10 options are mapped to this pathway in the Vault, including Diosmin, Hesperidin, Citrus Bioflavonoids, Horse Chestnut. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 10 carry clinical validation and 0 are mechanistic predictions.
Venous disease is a different problem from arterial disease and gets far less attention. D-dimer is the screen worth having if swelling is asymmetric or sudden. The markers worth checking are D-Dimer, Fibrinogen Activity, Complete Blood Count (CBC) with Differential, Ferritin.
Unproven is not the same as ineffective. Of the 10 options on this pathway, 10 have clinical validation and 0 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.